fiscal year As of fiscal year 2023, Washington University ranks 27th among U.S. institutions in total research and development (R&D) expenditures. In that year, Washington University reported $1.169 billion in R&D spending, reflecting an 11.7 percent increase from the previous year. In 2022, Washington University developed a nasal vaccine aimed at addressing COVID-19; it was licensed for use in India to Indian vaccine maker Bharat Biotech and the technology was licensed to bio-tech company Ocugen. Bharat named their licensed version of the vaccine iNCOVACC. In 2025, Washington University's' vaccine was approved for clinical trials in the United States.
In 2019, Washington University School of Medicine took over Folding@Home, a distributed computing project, from Stanford University. The project, which taps into the idle power of personal computers owned by volunteers to simulate protein folding, reached a speed of 1.5 exaFLOPS in 2020—seven times faster than the world's top supercomputer, Summit, and more powerful …
中文名/译名
SAT EBRW 25%
730
SAT EBRW 75%
770
SAT Math 25th %
770
SAT Math 75th %
800
ACT Composite 25th %
33
ACT Composite 50th %
34
ACT Composite 75th %
35
介绍+详细信息
Page 50 of 66
